We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy. By closing this message, you are consenting to our use of cookies.

Cancer Biology

All Life

The Cancer Biology Section of All Life publishes Research, Rapid Communications, Case Reports and Reviews covering all aspects of cancer research

All Life is linked with the UN’s Sustainable Development Goals. We invite researchers to share their latest research, data and opinions that work towards progressing solutions to Goal 3: Good Health and Well-being.

This section invites scientists to share their research activity with our broad readership. In this section of All Life we consider for publication the latest news on:

Cancer Initiation, Growth and Dissemination Mechanisms Genome and Epigenome Metabolism and Chemical Biology Pathophysiological Signalling
Tumour Biology and Cancer Stem Cells Technologies and Models to study cancer Translational Science Cancer Immunology and Immunotherapy
Therapy Response and Resistance to Therapies Clinical Trials Population and Prevention Science  

Meet the Section Editor

Editorial board for All Life

Pierre-Olivier Angrand, University of Lille, France

Pierre-Olivier Angrand is Professor in Molecular and Cell Biology at the University of Lille (France). He passed his PhD thesis at the Pasteur Institute in Paris in 1992, studying gene expression in rat hepatoma cells. After a first postdoctorate at the European Molecular Biology Laboratory (EMBL, Heidelberg, Germany) working on technologies for genome engineering, he moved to the Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC) in Strasbourg (France) where he discovered novel epigenetic regulators. In 2001, Pierre-Olivier Angrand was hired as a project leader in a start-up company in Heidelberg (Germany) to decipher signalling pathways using interaction proteomics. Now at the University of Lille, he has set-up a zebrafish facility aiming at developing zebrafish models of human diseases including cancer. Pierre-Olivier Angrand’s interest focuses on cancer epigenetics modelling in zebrafish.

Why Submit to All Life?

All Life is a fully Open Access journal to serve the ever-growing expansion of multi- and inter-disciplinary research in the life sciences:

  • Unique aims and scope welcoming truly multidisciplinary research in the life sciences.
  • Supporting the UN's Sustainable Development Goals for positive societal impact.
  • Pushing the boundaries of science by accepting submissions of negative/null data as well as replication and reproduction studies.
  • Promoting better information sharing through mandating public availability of all data associated with submissions.
  • Rigorous peer review process led by our team of subject experts across specialty sections.
  • Disseminating research that has an impact on all life.

Join our authors

Confused About Our Data Sharing Policy?

Authors are required to make the data and materials supporting their results or analyses freely available in a suitable repository under any Creative Commons license before submission. Click below to find out more and understand the steps you need to take before submission.
Learn More

Why Publish Open Access

Publishing open access can increase the reach and readership of your research.
Find out More

Get content alerts

Stay up to date with the latest articles by signing up to receive new content alerts
Sign up